Colgate-Palmolive Overview
Colgate-Palmolive Target Price
Analysts' 12-month price predictions for CL.
Share Price
$92.91
Average Target Price
$93.67
0.8% upside
0.8% upside3 analysts in the last 4 months
High: $96 | Low: $91
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-10 | Stifel NicolausMark Astrachan | $94 | 1.2% upside |  |
| 2024-04-08 | Evercore ISIRobert Ottenstein | $96 | 3.3% upside | |
| 2024-01-29 | Raymond JamesOlivia Tong | $91 |  2.1% downside | |
| 2023-07-28 | Wells FargoChris Casey | $81 | 12.8% downside | |
| 2023-01-13 | J.P. Morgan | $86 | 7.4% downside | |
| 2023-01-03 | Barclays | $80 | 13.9% downside | |
| 2022-12-06 | Deutsche Bank | $87 | 6.4% downside | |
| 2022-10-18 | Credit SuisseKaumil Gajrawala | $85 | 8.5% downside | |
| 2022-10-03 | Wells Fargo | $75 | 19.3% downside | |
| 2022-08-08 | Wells FargoChris Carey | $80 | 13.9% downside | |
| 2022-08-02 | Barclays | $74 | 20.4% downside | |
| 2022-08-01 | UBS | $90 | 3.1% downside | |
| 2022-07-21 | J.P. Morgan | $78 | 16% downside | |
| 2022-05-23 | Barclays | $71 | 23.6% downside | |
| 2022-05-03 | Barclays | $77 | 17.1% downside | |
| 2022-05-03 | Atlantic Equities | $80 | 13.9% downside | |
| 2022-05-02 | Deutsche Bank | $88 | 5.3% downside | |
| 2022-05-02 | Morgan Stanley | $82 | 11.7% downside | |
| 2022-04-30 | J.P. MorganAndrea Faria Teixeira | $79 | 15% downside | |
| 2022-04-03 | Goldman SachsJason English | $95 | 2.2% upside | |
| 2022-01-31 | CitigroupWendy Nicholson | $86 | 7.4% downside | |
| 2022-01-31 | Wells FargoChristopher Carey | $76 | 18.2% downside | |
| 2022-01-31 | Credit SuisseKaumil Gajrawala | $90 | 3.1% downside | |
| 2022-01-05 | JefferiesKevin Grundy | $89 | 4.2% downside | |
| 2021-10-05 | UBSPeter Grom | $89 | 4.2% downside | |
| 2021-10-05 | Bank of America SecuritiesBryan Spillane | $80 | 13.9% downside | |
| 2021-08-02 | Stifel NicolausMark Astrachan | $88 | 5.3% downside | |